Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Blood Donor Panel

To enable reliable, ready access to healthy human whole blood and blood-derived cells, Sygnature Discovery has established an internal blood donor panel of healthy volunteers which is supported by our Human Tissue Act Licence. Having this resource in-house aids the development of physiologically relevant and scalable assays for your project.

We have experience with whole-blood assays as well as with isolating and assaying a broad range of blood cell types, including, but not limited to: neutrophils, monocytes, T-cells, NK cells, eosinophils.

Sygnature Discovery also has access to fresh access to animal blood via our Strategic Alliance Partners, complimented further by access to diseased human blood/tissue from our established relationship with a local Biobank.

Blood-based assays can be tailored to address specific project requirements:

  • Fresh vs cryopreserved
  • Single donors or pooled
  • Different isolation methods fully validated (e.g. SepMate, Leucosep, density gradient sedimentation)
  • Ability to identify particular ‘biological’ responders (e.g. proliferation, response to biological stimuli, steroid resistance)


We have a wide range of experience in using healthy or diseased human whole blood or isolated blood cells in a range of different in vitro assay platforms:

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.